In This Article:
Key Insights
-
Significant control over XBiotech by individual investors implies that the general public has more power to influence management and governance-related decisions
-
A total of 23 investors have a majority stake in the company with 50% ownership
If you want to know who really controls XBiotech Inc. (NASDAQ:XBIT), then you'll have to look at the makeup of its share registry. With 49% stake, individual investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
And individual insiders on the other hand have a 35% ownership in the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own a fair bit of smaller companies.
Let's take a closer look to see what the different types of shareholders can tell us about XBiotech.
Check out our latest analysis for XBiotech
What Does The Institutional Ownership Tell Us About XBiotech?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
We can see that XBiotech does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of XBiotech, (below). Of course, keep in mind that there are other factors to consider, too.
Hedge funds don't have many shares in XBiotech. Thomas Gut is currently the company's largest shareholder with 13% of shares outstanding. In comparison, the second and third largest shareholders hold about 13% and 8.7% of the stock. Interestingly, the bottom two of the top three shareholders also hold the title of Chief Executive Officer and Member of the Board of Directors, respectively, suggesting that these insiders have a personal stake in the company.
A closer look at our ownership figures suggests that the top 23 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.